APA (7th ed.) Citation

Müller, N., Schwarz, M. J., Dehning, S., Douhe, A., Cerovecki, A., Goldstein-Müller, B., . . . Riedel, M. (2006). The cyclooxygenase-2 inhibitor celecoxib has therapeutic effects in major depression: Results of a double-blind, randomized, placebo controlled, add-on pilot study to reboxetine. Molecular psychiatry, 11(7), 680-684. https://doi.org/10.1038/sj.mp.4001805

Chicago Style (17th ed.) Citation

Müller, N., et al. "The Cyclooxygenase-2 Inhibitor Celecoxib Has Therapeutic Effects in Major Depression: Results of a Double-blind, Randomized, Placebo Controlled, Add-on Pilot Study to Reboxetine." Molecular Psychiatry 11, no. 7 (2006): 680-684. https://doi.org/10.1038/sj.mp.4001805.

MLA (9th ed.) Citation

Müller, N., et al. "The Cyclooxygenase-2 Inhibitor Celecoxib Has Therapeutic Effects in Major Depression: Results of a Double-blind, Randomized, Placebo Controlled, Add-on Pilot Study to Reboxetine." Molecular Psychiatry, vol. 11, no. 7, 2006, pp. 680-684, https://doi.org/10.1038/sj.mp.4001805.